Work

Refining post-blinatumomab risk stratification through ultrasensitive-based measurable residual disease assessment

Year: 2026
Type: article
Abstract: Not available.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,157
OpenAlex ID: W7154605359
FWCI:
Cites:
Cited by:
Related to: